Mental Health

Clearmind Medicine Announces First U.S. Clinical Site Initiation for CMND-100 Clinical Trial in Patients with Alcohol Use Disorder

Vancouver, Canada, April 10, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a…

9 months ago

Hazelden Betty Ford Foundation and Netsmart Collaborate to Enhance Behavioral Healthcare with Meaningful AI and Integrated CareFabric® Platform

OVERLAND PARK, Kan.--(BUSINESS WIRE)--#ArtificialIntelligence--The Hazelden Betty Ford Foundation, a leader in non-profit addiction and behavioral health treatment for 75 years,…

9 months ago

Cingulate Receives $3 Million Grant from Private Foundation to Accelerate Development of Anxiety Asset CTx-2103 (buspirone)

CTx-2103 has the Potential to be the First, Once-Daily Formulation of Buspirone, one of the Most Widely Prescribed Agents in…

9 months ago

WELL Health to Report Fourth Quarter and Year End 2024 Financial Results on April 14, 2025

VANCOUVER, BC, April 8, 2025 /PRNewswire/ - WELL Health Technologies Corp. (TSX: WELL) (OTCQX: WHTCF) ("WELL" or the "Company"), a digital…

9 months ago

Postbiotics Market to Reach $32.73 Million by 2032, Growing at a CAGR of 10.4% from 2025–Exclusive Report by Meticulous Research®

Market Growth Driven by Growing Awareness of Gut Health and Increasing Demand for Functional Food & Beverages REDDING, Calif., April…

9 months ago

RENPHO Expands Product Ecosystem with New LYNX Smart Ring

RENPHO Introduces the LYNX Smart Ring Revealing Bonds Between Lifestyle and Wellness IRVINE, Calif., April 8, 2025 /PRNewswire/ -- Leading…

9 months ago

Wave’s Reflect Launch Defines New Era of AI-Supported Mental Health Care

Combining structured, native, end-to-end data, a large and engaged user base and deep mental health domain expertise, Wave's AI product…

9 months ago

Mobile Health Integrates New Digital EAP into their Digital Health, Wellbeing, and Benefits Navigation platform at No-Additional-Cost

A Game-Changing Solution to Tackle Rising Health Costs, Mental Health Challenges, and Low EAP Utilization PALO ALTO, Calif., April 8, 2025…

9 months ago

Psyence BioMed Signs LOI with Southern Star Research to Expand Phase IIb Clinical Trial in Australia

New partnership strengthens Psyence BioMed's global clinical trial capabilities, accelerating the development of psilocybin-assisted therapy for adjustment disorderNew York, New…

9 months ago

GREATER MIAMI JEWISH FEDERATION RELEASES JEWISH MIAMI: A 2024 COMMUNITY STUDY

DEMOGRAPHIC FINDINGS SHOW CONTINUED GROWTH, TREMENDOUS DIVERSITY AND DEEP CONNECTIONS TO ISRAEL AND JEWISH LIFE MIAMI, April 7, 2025 /PRNewswire/…

10 months ago